Elevation of the soluble thrombomodulin levels is associated with inflammation after percutaneous coronary interventions

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Thrombomodulin (TM) is an endothelial cell surface thrombin-binding protein with anticoagulation ability by thrombin-mediated activation of protein C. An increase of plasma soluble TM level is reported to be associated with severity and worse outcome of coronary artery disease. Hypothesis: This prospective study investigated the relation of the elevated levels of plasma soluble TM and inflammatory and myonecrotic markers in patients undergoing percutaneous coronary intervention (PCI). Methods: Plasma levels of soluble TM, C-reactive protein (CRP), and creatine kinase and its MB isoenzyme were measured before and after PCI in 100 patients undergoing PCIs. Results: Peak TM levels after PCIs were significantly higher than baseline (3.39 ± 1.63 vs. 2.90 ± 1.57 ng/ml, p < 0.001). The peak TM levels after PCIs correlated significantly with the peak CRP and MB levels, and the maximal inflation duration (r = 0.423, p < 0.001; r = 0.212, p = 0.034; r = 0.307, p = 0.002, respectively). Conclusions: Soluble TM levels increase significantly after PCI. The elevation of the soluble TM after PCI shows better correlation with inflammation than myocardial injury, indicating an endothelial origin. Measurement of soluble TM could be useful and calls for further studies on the prognostic effects of this marker in this clinical condition.

Original languageEnglish
Pages (from-to)407-410
Number of pages4
JournalClinical Cardiology
Volume27
Issue number7
DOIs
Publication statusPublished - 2004 Jan 1

Fingerprint

Thrombomodulin
Percutaneous Coronary Intervention
Inflammation
Thrombin
C-Reactive Protein
Economic Inflation
Creatine Kinase
Protein C
Protein Kinases
Isoenzymes
Coronary Artery Disease
Carrier Proteins
Endothelial Cells
Biomarkers
Prospective Studies

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

@article{7be7dd63c5414a20b2804437e8bda9e5,
title = "Elevation of the soluble thrombomodulin levels is associated with inflammation after percutaneous coronary interventions",
abstract = "Background: Thrombomodulin (TM) is an endothelial cell surface thrombin-binding protein with anticoagulation ability by thrombin-mediated activation of protein C. An increase of plasma soluble TM level is reported to be associated with severity and worse outcome of coronary artery disease. Hypothesis: This prospective study investigated the relation of the elevated levels of plasma soluble TM and inflammatory and myonecrotic markers in patients undergoing percutaneous coronary intervention (PCI). Methods: Plasma levels of soluble TM, C-reactive protein (CRP), and creatine kinase and its MB isoenzyme were measured before and after PCI in 100 patients undergoing PCIs. Results: Peak TM levels after PCIs were significantly higher than baseline (3.39 ± 1.63 vs. 2.90 ± 1.57 ng/ml, p < 0.001). The peak TM levels after PCIs correlated significantly with the peak CRP and MB levels, and the maximal inflation duration (r = 0.423, p < 0.001; r = 0.212, p = 0.034; r = 0.307, p = 0.002, respectively). Conclusions: Soluble TM levels increase significantly after PCI. The elevation of the soluble TM after PCI shows better correlation with inflammation than myocardial injury, indicating an endothelial origin. Measurement of soluble TM could be useful and calls for further studies on the prognostic effects of this marker in this clinical condition.",
author = "Ting-Hsing Chao and Yi-Heng Li and Wei-Chuan Tsai and Chen, {Jyh Hong} and Ping-Yen Liu and Liang-Miin Tsai",
year = "2004",
month = "1",
day = "1",
doi = "10.1002/clc.4960270708",
language = "English",
volume = "27",
pages = "407--410",
journal = "Clinical Cardiology",
issn = "0160-9289",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Elevation of the soluble thrombomodulin levels is associated with inflammation after percutaneous coronary interventions

AU - Chao, Ting-Hsing

AU - Li, Yi-Heng

AU - Tsai, Wei-Chuan

AU - Chen, Jyh Hong

AU - Liu, Ping-Yen

AU - Tsai, Liang-Miin

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Background: Thrombomodulin (TM) is an endothelial cell surface thrombin-binding protein with anticoagulation ability by thrombin-mediated activation of protein C. An increase of plasma soluble TM level is reported to be associated with severity and worse outcome of coronary artery disease. Hypothesis: This prospective study investigated the relation of the elevated levels of plasma soluble TM and inflammatory and myonecrotic markers in patients undergoing percutaneous coronary intervention (PCI). Methods: Plasma levels of soluble TM, C-reactive protein (CRP), and creatine kinase and its MB isoenzyme were measured before and after PCI in 100 patients undergoing PCIs. Results: Peak TM levels after PCIs were significantly higher than baseline (3.39 ± 1.63 vs. 2.90 ± 1.57 ng/ml, p < 0.001). The peak TM levels after PCIs correlated significantly with the peak CRP and MB levels, and the maximal inflation duration (r = 0.423, p < 0.001; r = 0.212, p = 0.034; r = 0.307, p = 0.002, respectively). Conclusions: Soluble TM levels increase significantly after PCI. The elevation of the soluble TM after PCI shows better correlation with inflammation than myocardial injury, indicating an endothelial origin. Measurement of soluble TM could be useful and calls for further studies on the prognostic effects of this marker in this clinical condition.

AB - Background: Thrombomodulin (TM) is an endothelial cell surface thrombin-binding protein with anticoagulation ability by thrombin-mediated activation of protein C. An increase of plasma soluble TM level is reported to be associated with severity and worse outcome of coronary artery disease. Hypothesis: This prospective study investigated the relation of the elevated levels of plasma soluble TM and inflammatory and myonecrotic markers in patients undergoing percutaneous coronary intervention (PCI). Methods: Plasma levels of soluble TM, C-reactive protein (CRP), and creatine kinase and its MB isoenzyme were measured before and after PCI in 100 patients undergoing PCIs. Results: Peak TM levels after PCIs were significantly higher than baseline (3.39 ± 1.63 vs. 2.90 ± 1.57 ng/ml, p < 0.001). The peak TM levels after PCIs correlated significantly with the peak CRP and MB levels, and the maximal inflation duration (r = 0.423, p < 0.001; r = 0.212, p = 0.034; r = 0.307, p = 0.002, respectively). Conclusions: Soluble TM levels increase significantly after PCI. The elevation of the soluble TM after PCI shows better correlation with inflammation than myocardial injury, indicating an endothelial origin. Measurement of soluble TM could be useful and calls for further studies on the prognostic effects of this marker in this clinical condition.

UR - http://www.scopus.com/inward/record.url?scp=3042725341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042725341&partnerID=8YFLogxK

U2 - 10.1002/clc.4960270708

DO - 10.1002/clc.4960270708

M3 - Article

C2 - 15298041

AN - SCOPUS:3042725341

VL - 27

SP - 407

EP - 410

JO - Clinical Cardiology

JF - Clinical Cardiology

SN - 0160-9289

IS - 7

ER -